Delivery Order SPE2DB20D1100-SPE2DB24FZ87F
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $18,218.68 firm-fixed-price delivery order is for the pharmaceutical product Biktarvy 50-200-25 mg Tablet, with an ultimate completion date of November 7, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $22,982.83 delivery order covers the supply of Biktarvy 50-200-25 30S, a prescription medication, to support military healthcare programs. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Firm Fixed Price Delivery Order worth $76,466.38 awarded by the Defense Logistics Agency (DLA). The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, and has an ultimate completion date of March 1, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government. The prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a Delivery Order (SPE2DX22FCEK5) valued at $92,495.09 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The contract covers the delivery of Biktarvy 50-200-25 mg tablets to support military and veterans' healthcare programs....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, which does not have a set-aside designation, covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $184,789.80 firm fixed-price delivery order contract is for the supply of Biktarvy 50-200-25 mg tablets. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award, with ID SPE2DX15D1053|SPE2DX23F6HWK, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $31,522.95 delivery order is for the supply of Biktarvy 50-200-25 mg tablets and has a completion date of February 27, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the...
- This federal contract award, valued at $5,654.63, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $7,525.83 for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of May 1, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $54,991.16 for the supply of BIKTARVY 50-200-25 MG TABLET. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of March 11, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FZ87FDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $102,220.74 delivery order contract is for the supply of pharmaceutical products, including the HIV medication Biktarvy 50-200-25 mg tablets. The contract has a period of performance ending on January 24, 2024 and utilizes a firm fixed price pricing structure. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award is not designated as a set-aside. The contract supports the provision of essential pharmaceutical and medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $102.2k | 1/23/24 |